CAMBRIDGE, Mass.--(BUSINESS WIRE)--HyperLight, creator of the TFLN Chipletâ„¢ platform, today announced the launch of its groundbreaking 110 GHz Low VÏ€ Intensity Modulator, featuring industry-standard ...
Temozolomide combined with radiation as first-line treatment in primary glioblastoma multiforme: Phase I/II-study No significant financial relationships to disclose. This is an ASCO Meeting Abstract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results